Clinical Trials Browser

Phase 2 × Appendiceal Neoplasms × Gynecologic × Clear all

NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

Phase 2 Completed

21 enrolled 21 charts

BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05913674 2026-05-14

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

Phase 2 Recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms

NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Phase 2 Recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Phase 2 Completed

51 enrolled 12 charts

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT03073694 2023-06-09

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

Phase 2 Unknown

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT03246321 2019-10-15

CRC-PIPAC

Phase 2 Completed

GastrointestinalGynecologic

Appendiceal Neoplasms, Cecal Neoplasms, Intraoperative Complications, Neoplasms, Peritoneal Neoplasms, Postoperative Complications, Colorectal Neoplasms, Drug-Related Side Effects and Adverse Reactions